Poly Medicure Limited has informed the Exchange about Investors/Analyst Call on Financial Results for the Quarter and Nine Months ended on December 31, 2025 i.e. Q3FY26 under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure Limited has informed the stock exchanges that it will hold an investors and analyst call to discuss its financial results for the third quarter and nine months ended December 31, 2025 (Q3FY26). This is a routine disclosure made under SEBI's listing regulations, where companies notify the exchange in advance about scheduled investor interactions. The company has not shared any financial numbers, guidance, or specific outcomes in this filing — it is purely a notice about the upcoming call.
This is a routine regulatory intimation with no direct impact on the stock price. Investors should watch for the actual Q3FY26 financial results, which will likely be detailed during the call and may move the stock depending on performance versus expectations.